References
- Aebi, H., 1984. Catalase in vitro. Methods in Enzymology, 105, 121–126.
- Alexander, S.P.H., CGTP Collaborators., et al., 2013. The Concise Guide to pharmacology 2013/14: ligand-gated ion channels. British Journal of Pharmacology, 170(8), 1582–1607.
- Arya, V., et al., 2013. Does an increase in serum creatinine always reflect renal injury? The case of Stribild®. The Journal of Clinical Pharmacology, 54(3), 279–281.
- Arya, V., et al., 2014. Creatinine as an endogenous marker for renal function – emerging role of transporters in the overall assessment of renal toxicity. PII-012. Clinical Pharmacology and Therapeutic, 95:S65.
- Asconape, J.J., 2014. Use of antiepileptic drugs in hepatic and renal disease. Handbook of Clinical Neurology, 119, 417–432.
- Asija, R., et al., 2014. Hepatoprotective models and screening methods: a review. Journal of Drug Discovery and Therapeutics, 2(21), 49–56.
- Bancroft, J. D., and Gamble, M., 2008. Theory and practice of histological techniques. Philadelphia, PA: Elsevier Health Sciences.
- Biton, V.1., 2003. Effect of antiepileptic drugs on bodyweight: overview and clinical implications for the treatment of epilepsy. CNS Drugs, 17(11), 781–791.
- Bjornsson, E., 2008. Hepatotoxicity associated with antiepileptic drugs. Acta Neurologica Scandinavica, 118(5), 281–290.
- Bjoro, K., et al., 1998. Topiramate and fulminant liver failure. Lancet, 352(9134), 1119.
- Breyer, M.D., and Qi, Z., 2010. Better nephrology for mice-and man. Kidney International, 77(6), 487–489.
- Bumb, A., Diederich, N., and Beyenburg, S., 2003. Adding topiramate to valproate therapy may cause reversible hepatic failure. Epileptic Disorders, 5(3), 157–159.
- Carroll, J.J., et al., 1971. Simplified alkaline phosphotungstate assay for uric acid in serum. Clinical Chemistry, 17(3), 158.
- Chu, X., et al., 2016. The complexities of interpreting reversible elevated serum creatinine levels in drug development: does a correlation with inhibition of renal transporters exist? Drug Metabolism and Disposition, 44(9), 1498–1509.
- Craig, A.E., Yan, Z., and Zhao, Q., 2015. The relationship between chemical-induced kidney weight increases and kidney histopathology in rats. Journal of Applied Toxicology, 35(7), 729–773.
- Dell’Orto, V.G., et al., 2014. Metabolic disturbances and renal stone promotion on treatment with topiramate: a systematic review. British Journal of Clinical Pharmacology, 77, 958–964.
- Doan, R.J., and Clendenning, M., 2000. Topiramate and hepatotoxicity. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 45(10), 937–938.
- Eissa, I.F., et al., 2018. Improved effect of pumpkin seed oil against the bisphenol-A adverse effects in male mice. Toxicology Reports, 5, 857–863.
- El Makawy, I.A., et al., 2019. Effect of antiepileptic drug (Topiramate) and cold pressed ginger oil on testicular genes expression, sexual hormones and histopathological alterations in mice. Biomedicine & Pharmacotherapy, 110, 409–419.
- EL-Shorbagy, M.H., and Hamdi, H., 2016. Genotoxic and mutagenic studies of the antiepileptic drug levetiracetam in pregnant rats and their fetuses. International Journal of Pharmacy and Pharmaceutical Science, 8(2), 82–88.
- Fridovich, I., 1974. Superoxide dismutases. Advances in Enzymology and Related Areas of Molecular Biology, 41, 35–97.
- Galaly, R.S., et al., 2014. Effects of royal jelly on genotoxicity and nephrotoxicity induced by valproic acid in albino mice. Beni-Suef University Journal of Basic and Applied Sciences, 3(1), 1–1 5.,
- George, M., Joseph, L., and Jose, C.P., 2016. A review article on assessing the effect of antiepileptics and statins on liver enzymes in epileptic patients. The Pharma Innovation Journal, 5(3), 11–14.
- Giordano, C., et al., 2015. Uric acid as a marker of kidney disease: review of the current literature. Disease Markers, 382918, 1–6.
- Gracia-Sancho, J., et al., 2007. Increased oxidative stress in cirrhotic rat livers: a potential mechanism contributing to reduced nitric oxide bioavailability. Hepatology, 47(4), 1248–1256.
- Guicciardi, E.M., et al., 2013. Apoptosis and necrosis in the liver. Comprehensive Physiology, 3(2), 977–1010.
- Hamed, S.A., 2017. The effect of antiepileptic drugs on the kidney function and structure. Expert Review of Clinical Pharmacology, 10(9), 993–1006.
- Hamed, S.A., Abdellah, M.M., and El-Melegy, N., 2004. Blood levels of trace elements, electrolytes and oxidative stress/antioxidant systems in epileptic patients. Journal of Pharmacological Sciences, 96(4), 465–473.
- Hussein, R.S.R., et al., 2013. Effect of antiepileptic drugs on liver enzymes. Beni-Suef University Journal of Basic and Applied Sciences, 2(1), 14–19.
- Larsen, K., 1972. Creatinine assay by a reaction-kinetic principle. Clinica Chimica Acta, 41, 209–217.
- Marmura, J.M., 2014. Safety of topiramate for treating migraines. Expert Opinion on Drug Safety, 13(9), 1241–1247.
- Martín-Burriel, I., et al., 2004. Histopathological and molecular changes during apoptosis produced by 7H-dibenzo [c,g]-carbazole in mouse liver. Toxicologic Pathology, 32(2), 202–211.
- Meshkibaf, M.H., et al., 2006. Choronic effects of lamotrigine on liver function in adult male rats. Indian Journal of Clinical Biochemistry, 21(1), 161–164.
- Mirza, N., Marson, A.G., and Pirmohamed, M., 2009. Effect of topiramate on acid-base balance: extent, mechanism and effects. British Journal of Clinical Pharmacology, 68(5), 655–666.
- Mitchell, L.E., et al., 2004. Spina bifida. The Lancet, 364(9448), 1885–1895.
- Moller, P., et al., 2014. On the search for an intelligible comet assay descriptor. Frontiers in Genetics, 5, 217.
- Montgomery, H.A.C., and Dymock, J., 1961. The determination of nitrite in water. Analyst, 86, 414–416.
- Mutawakil, H.Z.M., et al., 2014. Evaluation of the potential genotoxicity of antibiotics alternative probiotics used in livestock and poultry. Journal of Food and Agriculture Environment, 12(2), 389–396.
- Ohkawa, H., Ohishi, N., and Yagi, K., 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry, 95(2), 351–358.
- Ozaki, M., Haga, S., and Ozawa, T., 2012. In vivo monitoring of liver damage using caspase-3 probe. Theranostics, 2(2), 207–214.
- Pippenger, C.E., 2003. Pharmacology of neural tube defects. Epilepsia, 44(Suppl. 3), 24–32.
- Poorrostami, A., Farokhi, F., and Heidari, R., 2014. Effect of hydroalcoholic extract of ginger on the liver of epileptic female rats treated with lamotrigine. Avicenna Journal of Phytomedicine, 4(4), 276–286.
- Price, O.T., et al., 2012. Topiramate treatment protects blood-brain barrier pericytes from hyperglycemia-induced oxidative damage in diabetic mice. Endocrinology, 153(1), 362–372.
- Reitman, S., and Frankel, S., 1957. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. American Journal of Clinical Pathology, 28(1), 56–63.
- Ryu, E.S., et al., 2013. Uric acid-induced phenotypic transition of renal tubular cells as a novel mechanism of chronic kidney disease. American Journal of Physiology-Renal Physiology, 304(5), F471–F480.
- Salah El-Din, Y.E., and Omar, R.A., 2017. Effect of prenatal administration of therapeutic dose of topiramate on placentae albino rats' fetuses. International Journal of Pharmacy and Pharmaceutical Sciences, 9(3), 54–59.
- Schulpis, K.H., et al., 2006. Valproic acid monotherapy induces DNA oxidative damage. Toxicology, 217(2-3), 228–232.
- Sheth, R.D., and Montouris, G., 2008. Metabolic effects of AEDs: impact on body weight, lipids and glucose metabolism. International Review of Neurobiology, 83, 329–346.
- Siemes, H., et al., 1993. Valproate (VPA) metabolites in various clinical conditions of probable VPA-associated hepatotoxicity. Epilepsia, 34(2), 332–346.
- Spritzer, D.S., Bravo, P.T., and Drazkowski, F.J., 2016. Topiramate for treatment in patients with migraine and epilepsy. Headache, 56(6), 1081–1085.
- Tan, H.K., Rudrappa, S., and Tang, C.H., 2014. Renal tubular acidosis following topiramate. Journal of Medical Cases, 5(12), 634–635.
- Verrotti, A., et al., 2008. Increased oxidative stress in epileptic children treated with valproic acid. Epilepsy Research, 78(2-3), 171–177.
- Verzola, D., et al., 2014. Uric acid promotes apoptosis in human proximal tubule cells by oxidative stress and activation of NAPDH oxidase NOX 4. PLoS One, 9(12), e115210. Article ID e115210,
- Waikar, S.S., et al., 2012. Imperfect gold standards for kidney injury biomarker evaluation. Journal of the American Society of Nephrology, 23(1), 13–21.
- Witczak, M., et al., 2010. Evaluation of chromosome aberrations, sister chromatid exchange and micronuclei in cultured cord-blood lymphocytes of newborns of women treated for epilepsy during pregnancy. Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 701(2), 111–117.
- Yang, M., et al., 2014. Biomarkers distinguish apoptotic and necrotic cell death during hepatic ischemia-reperfusion injury in mice. Liver Transplantation, 20(11), 1372–1382.